Back to Search
Start Over
A response to the commentary "Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms" by Loftis, J.M. on "Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms" by Udina, M., Moreno-España, J., Navinés, R., Gimenez, D., Langohr, K., Gratacòs, M., Capuron, L., de la Torre, R., Solà, R., Martin-Santos, R. http:\\dx.doi.org/10.1016/j.psyneuen.2013.03.007.
- Source :
-
Psychoneuroendocrinology [Psychoneuroendocrinology] 2013 Sep; Vol. 38 (9), pp. 1830-1. Date of Electronic Publication: 2013 Jun 28. - Publication Year :
- 2013
- Subjects :
- Humans
Recombinant Proteins adverse effects
Antiviral Agents adverse effects
Anxiety chemically induced
Depression chemically induced
Fatigue chemically induced
Hepatitis C, Chronic drug therapy
INDEL Mutation
Interferon-alpha adverse effects
Interleukin-6 genetics
Point Mutation
Polyethylene Glycols adverse effects
Serotonin physiology
Serotonin Plasma Membrane Transport Proteins genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1873-3360
- Volume :
- 38
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Psychoneuroendocrinology
- Publication Type :
- Report
- Accession number :
- 23810434
- Full Text :
- https://doi.org/10.1016/j.psyneuen.2013.05.019